Januvia sitagliptin: Phase III data

Data from 497 patients with baseline HbA1c of 8-12% showed that first line Januvia plus Actos pioglitazone reduced HbA1c by 2.4% from baseline vs. 1.5% for Actos alone at 24 weeks (p<0.001). The comb...